ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)

Name: ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)
License: Public Domain

Second Xiangya Hospital of Central South University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

non-small-cell-lung-cancer

non small cell lung cancer, immune checkpoint inhibitors (icis)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 279487
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.